Literature DB >> 26257334

Maturational alterations in constitutive activity of medial prefrontal cortex kappa-opioid receptors in Wistar rats.

Sunil Sirohi1,2, Brendan M Walker1,2,3,4.   

Abstract

Opioid receptors can display spontaneous agonist-independent G-protein signaling (basal signaling/constitutive activity). While constitutive κ-opioid receptor (KOR) activity has been documented in vitro, it remains unknown if KORs are constitutively active in native systems. Using [(35) S] guanosine 5'-O-[gamma-thio] triphosphate coupling assay that measures receptor functional state, we identified the presence of medial prefrontal cortex KOR constitutive activity in young rats that declined with age. Furthermore, basal signaling showed an age-related decline and was insensitive to neutral opioid antagonist challenge. Collectively, the present data are first to demonstrate age-dependent alterations in the medial prefrontal cortex KOR constitutive activity in rats and changes in the constitutive activity of KORs can differentially impact KOR ligand efficacy. These data provide novel insights into the functional properties of the KOR system and warrant further consideration of KOR constitutive activity in normal and pathophysiological behavior. Opioid receptors exhibit agonist-independent constitutive activity; however, kappa-opioid receptor (KOR) constitutive activity has not been demonstrated in native systems. Our results confirm KOR constitutive activity in the medial prefrontal cortex (mPFC) that declines with age. With the ability to presynaptically inhibit multiple neurotransmitter systems in the mPFC, maturational or patho-logical alterations in constitutive activity could disrupt corticofugal glutamatergic pyramidal projection neurons mediating executive function. Regulation of KOR constitutive activity could serve as a therapeutic target to treat compromised executive function.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  age; constitutive activity; dynorphin; negative efficacy antagonist; nor-binaltorphimine; κ-opioid receptors

Mesh:

Substances:

Year:  2015        PMID: 26257334      PMCID: PMC4636924          DOI: 10.1111/jnc.13279

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  53 in total

Review 1.  Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective.

Authors:  Graeme Milligan
Journal:  Mol Pharmacol       Date:  2003-12       Impact factor: 4.436

2.  The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction.

Authors:  Igor Bazov; Olga Kononenko; Hiroyuki Watanabe; Vesna Kuntić; Daniil Sarkisyan; Malik M Taqi; Muhammad Z Hussain; Fred Nyberg; Tatjana Yakovleva; Georgy Bakalkin
Journal:  Addict Biol       Date:  2011-09-28       Impact factor: 4.280

3.  Prefrontal Cortical Kappa Opioid Receptors Attenuate Responses to Amygdala Inputs.

Authors:  Hugo A Tejeda; Ashley N Hanks; Liam Scott; Carlos Mejias-Aponte; Zoë A Hughes; Patricio O'Donnell
Journal:  Neuropsychopharmacology       Date:  2015-05-14       Impact factor: 7.853

4.  Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors.

Authors:  Jessica L Kissler; Brendan M Walker
Journal:  Neuropsychopharmacology       Date:  2015-06-24       Impact factor: 7.853

5.  Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on κ-opioid receptors.

Authors:  Kshitij A Patkar; Jinhua Wu; Michelle L Ganno; Harminder D Singh; Nicolette C Ross; Khampaseuth Rasakham; Lawrence Toll; Jay P McLaughlin
Journal:  J Pharmacol Exp Ther       Date:  2013-07-12       Impact factor: 4.030

6.  The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors.

Authors:  Jessica L Kissler; Sunil Sirohi; Daniel J Reis; Heiko T Jansen; Raymond M Quock; Daniel G Smith; Brendan M Walker
Journal:  Biol Psychiatry       Date:  2013-04-21       Impact factor: 13.382

7.  Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.

Authors:  Brendan M Walker; Jessica L Kissler
Journal:  Neuropsychopharmacology       Date:  2013-05-21       Impact factor: 7.853

8.  Pharmacological activation of kappa opioid receptors: aversive effects in adolescent and adult male rats.

Authors:  Rachel I Anderson; Melissa Morales; Linda P Spear; Elena I Varlinskaya
Journal:  Psychopharmacology (Berl)       Date:  2013-04-19       Impact factor: 4.530

9.  Possible role of dynorphins in Alzheimer's disease and age-related cognitive deficits.

Authors:  Caroline Ménard; Herbert Herzog; Christoph Schwarzer; Rémi Quirion
Journal:  Neurodegener Dis       Date:  2013-08-22       Impact factor: 2.977

10.  Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters.

Authors:  Thomas A Munro; Xi-Ping Huang; Carmela Inglese; Maria Grazia Perrone; Ashlee Van't Veer; F Ivy Carroll; Cécile Béguin; William A Carlezon; Nicola A Colabufo; Bruce M Cohen; Bryan L Roth
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more
  7 in total

1.  Tau Protein Levels in ADHD.

Authors:  Keith Fluegge
Journal:  Indian J Clin Biochem       Date:  2018-04-19

Review 2.  Opioid modulation of cognitive impairment in depression.

Authors:  Moriah L Jacobson; Hildegard A Wulf; Caroline A Browne; Irwin Lucki
Journal:  Prog Brain Res       Date:  2018-09-18       Impact factor: 2.453

Review 3.  Neuropeptide System Regulation of Prefrontal Cortex Circuitry: Implications for Neuropsychiatric Disorders.

Authors:  Sanne M Casello; Rodolfo J Flores; Hector E Yarur; Huikun Wang; Monique Awanyai; Miguel A Arenivar; Rosario B Jaime-Lara; Hector Bravo-Rivera; Hugo A Tejeda
Journal:  Front Neural Circuits       Date:  2022-06-21       Impact factor: 3.342

4.  Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress.

Authors:  Abigail M Polter; Kelsey Barcomb; Rudy W Chen; Paige M Dingess; Nicholas M Graziane; Travis E Brown; Julie A Kauer
Journal:  Elife       Date:  2017-04-12       Impact factor: 8.140

5.  A model of lipid dysregulation and altered nutrient status in Alzheimer's disease.

Authors:  Keith Fluegge
Journal:  Alzheimers Dement (N Y)       Date:  2019-04-30

6.  Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands.

Authors:  Chiara Sturaro; Davide Malfacini; Michela Argentieri; Francine M Djeujo; Erika Marzola; Valentina Albanese; Chiara Ruzza; Remo Guerrini; Girolamo Calo'; Paola Molinari
Journal:  Front Pharmacol       Date:  2022-04-21       Impact factor: 5.988

Review 7.  Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo.

Authors:  Muzeyyen Ugur; Lyes Derouiche; Dominique Massotte
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.